These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8507864)

  • 1. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits.
    Griffin LC; Tidmarsh GF; Bock LC; Toole JJ; Leung LL
    Blood; 1993 Jun; 81(12):3271-6. PubMed ID: 8507864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation.
    Li WX; Kaplan AV; Grant GW; Toole JJ; Leung LL
    Blood; 1994 Feb; 83(3):677-82. PubMed ID: 8298130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
    Bompiani KM; Monroe DM; Church FC; Sullenger BA
    J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass.
    DeAnda A; Coutre SE; Moon MR; Vial CM; Griffin LC; Law VS; Komeda M; Leung LL; Miller DC
    Ann Thorac Surg; 1994 Aug; 58(2):344-50. PubMed ID: 8067830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of combinatorial libraries and protein engineering to the discovery of novel anti-thrombotic drugs.
    Leung LL
    Thromb Haemost; 1995 Jul; 74(1):373-6. PubMed ID: 8578488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin.
    Boncler MA; Koziolkiewicz M; Watala C
    Thromb Res; 2001 Nov; 104(3):215-22. PubMed ID: 11672764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
    Müller J; Freitag D; Mayer G; Pötzsch B
    J Thromb Haemost; 2008 Dec; 6(12):2105-12. PubMed ID: 18826387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant effects of thioanalogs of thrombin-binding DNA-aptamer and their stability in the plasma.
    Pozmogova GE; Zaitseva MA; Smirnov IP; Shvachko AG; Murina MA; Sergeenko VI
    Bull Exp Biol Med; 2010 Dec; 150(2):180-4. PubMed ID: 21240367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
    Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
    Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix.
    Mendelboum Raviv S; Horváth A; Aradi J; Bagoly Z; Fazakas F; Batta Z; Muszbek L; Hársfalvi J
    J Thromb Haemost; 2008 Oct; 6(10):1764-71. PubMed ID: 18665927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo.
    Tsiang M; Paborsky LR; Li WX; Jain AK; Mao CT; Dunn KE; Lee DW; Matsumura SY; Matteucci MD; Coutré SE; Leung LL; Gibbs CS
    Biochemistry; 1996 Dec; 35(51):16449-57. PubMed ID: 8987977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and characterization of a novel nucleotide-based thrombin inhibitor.
    Griffin LC; Toole JJ; Leung LL
    Gene; 1993 Dec; 137(1):25-31. PubMed ID: 8282198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
    Tanaka KA; Szlam F; Rusconi CP; Levy JH
    Thromb Haemost; 2009 May; 101(5):827-33. PubMed ID: 19404534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and functional characterization of DNA-derived aptamers that act as thrombin inhibitors in human platelets and coagulation assays.
    Bracht F; Schrör K
    Agents Actions Suppl; 1995; 45():315-22. PubMed ID: 7717196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of a new DNA aptamer, direct inhibitor of thrombin.
    Mazurov AV; Titaeva EV; Khaspekova SG; Storojilova AN; Spiridonova VA; Kopylov AM; Dobrovolsky AB
    Bull Exp Biol Med; 2011 Feb; 150(4):422-5. PubMed ID: 22268033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.
    Soule EE; Bompiani KM; Woodruff RS; Sullenger BA
    Nucleic Acid Ther; 2016 Feb; 26(1):1-9. PubMed ID: 26584417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for thrombin in platelet aggregation under high shear stress.
    Sakurai Y; Shima M; Giddings J; Takeyama M; Kasuda S; Nogami K; Nishiya K; Yoshioka A
    Thromb Res; 2004; 113(5):311-8. PubMed ID: 15183043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkages.
    He GX; Williams JP; Postich MJ; Swaminathan S; Shea RG; Terhorst T; Law VS; Mao CT; Sueoka C; Coutré S; Bischofberger N
    J Med Chem; 1998 Oct; 41(22):4224-31. PubMed ID: 9784097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.